Results 231 to 240 of about 5,691,277 (301)

Modes of cannabis administration, cannabis and tobacco co-use, and associations with respiratory and cannabis use outcomes in a permissive medical cannabis state. [PDF]

Addict Behav
Cohn A, Romm KF, Vogel EA, Pan S, Frank-Pearce SG, Smith MA, Appleseth H, Boozary L, Sifat MS, Kendzor DE.   +9 more
europepmc   +1 more source

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade, Nathan Morris, Diana E. Sepulveda, Alonso Cortez‐Resendiz, Christopher Brandl, Jennifer E. Lausch, Mariya Starostina, Nicholas M. Graziane   +7 more
wiley   +1 more source

From card to cradle: examining medical cannabis purchasing among pregnant women in Arkansas. [PDF]

Am J Obstet Gynecol MFM
ElHassan NO, Farnam C, Thompson JW, Stanley N, Hayes CJ, Li C, Mourani PM, Hudson TJ, Mcgehee R, Martin BC.   +9 more
europepmc   +1 more source

The fight of innate immunity and abnormal cannabinoids against Candida infection

British Journal of Pharmacology, EarlyView.
Candida species represent the most clinically significant fungal pathogens in humans, with invasive candidiasis carrying a mortality of 30%–40% in critically ill patients despite modern antifungal therapy. The innate immune system – through the coordinated and specific activities of neutrophils, macrophages, NK cells, mast cells and eosinophils ...
Prince Ofori, Ilan Zaffran, Francesca Levi Schaffer   +2 more
wiley   +1 more source

From farm to bedside: Potential of medical cannabis in global health. [PDF]

Complement Ther Med
Tendwa MB, Appidi T, Chitsunge B, Moreau M, Okole B, Kalombo L, Mallum A, Ngoma T, Weadock DP, Tanifum E, Erridge S, Sodergren M, Sims R, Johnson C, Toyang N, Lowe H, Ziberi B, Richner L, Carrillo S, Avery S, Pretorius J, Chikwamba R, Biteghe FAN, Grinspoon P, Strichtartz G, Yasmin-Karim S, Ngwa W.   +26 more
europepmc   +1 more source

Exploring the acceptability and feasibility of a blended imagery‐based digital intervention for self‐harm in young people (Imaginator 2.0): a co‐produced qualitative study

Child and Adolescent Mental Health, EarlyView.
Background Around 20% of 12‐ to 25‐year‐olds experience self‐harm, but interventions deemed both acceptable and effective in reducing self‐harm behaviour are rare. Digital interventions can be effective; however, they often lack sustained engagement and co‐design.
Lindsay H. Dewa, Athina Servi, Emily Gardner‐Bougaard, Saida Jabril Mohamed, Aaron McDermott, Ben Aveyard, Rachel Rodrigues, Adam Hampshire, Nejra Van Zalk, Martina Di Simplicio   +9 more
wiley   +1 more source

Misinformation About Medical Cannabis in YouTube Videos: Systematic Review. [PDF]

JMIR Form Res
Khare S, Erridge S, Chidambaram S, Sodergren MH.   +3 more
europepmc   +1 more source

Cofactors in Anaphylaxis: Insights From the European Anaphylaxis Registry

Clinical &Experimental Allergy, EarlyView.
Forty‐nine per cent of reactions reported suspected cofactors (26% of children/adolescents, 59% of adults). Adjusted odds ratios for reaction severity increased with increasing number of suspected cofactors. Consistent effects for individual suspected cofactors were only observed for acute infections (children) and alcohol (adults with food‐induced ...
Margitta Worm, Sabine Dölle‐Bierke, Guillaume Pouessel, Franziska Ruëff, Karin Hartmann, Claudia Pföhler, Maria Beatrice Bilò, Nicola Wagner, Nikolaos G. Papadopoulos, Lars Lange, Andrea Bauer, Johannes Trück, Paul J. Turner, Veronika Höfer   +13 more
wiley   +1 more source

Concerns, Beliefs and Attitudes of Pharmacists About Medical Cannabis Use in Poland. [PDF]

Healthcare (Basel)
Merks P, Cameron J, Kazmierczak J, Białkowski A, Świetlik D, Borowska M, Wierzba W, Bołkun-Skórnicka U, Śliż D, Blicharska E, Fedorowski J, Vaillancourt R, Religioni U.   +12 more
europepmc   +1 more source

Pharmacological and non‐pharmacological interventions for managing sleep disorders in children with cerebral palsy: A systematic review

Developmental Medicine &Child Neurology, EarlyView.
xxxxxx Aim To systematically review the effectiveness, safety, and economic evidence of pharmacological and non‐pharmacological interventions for sleep disorders in children with cerebral palsy (CP). Method Databases including MEDLINE, Embase, CENTRAL (the Cochrane Library), International Clinical Trials Registry Platform of the World Health ...
Nishant Jaiswal, Lizzie Fisher, Giorgio Ciminata, Ryan Mulholland, Anna Noel‐Storr, Lesley Nutton, Valerie Orr, Paul Eunson, Nicola J. Cooper, Alex Sutton, Olivia Wu, Terry Quinn   +11 more
wiley   +1 more source